Visibly Different | EnvisionRx | Perspective on the Rx Pipeline

Not getting email updates?

Home
Subscribe
Contact Us
EnvisionRx.com

Blog Home
Contact Us

SEARCH

Search this site on Google

SEARCH

Instant Insights

Don't wait to get cost saving and care improving insights.
Subscribe for instant insights!

Filter Insights By...

Clinical Trends & Insights (37)
Solutions & Best Practices (34)
Industry Updates (26)
Getting to Know ERx (19)
Perspective on the Rx Pipeline (19)

Instant Insights

New Therapeutic Class Could Bring Relief to Migraine Sufferers, But At What Cost?

Perspective on the Rx Pipeline - The Pros and Cons of the Calcitonin Gene-Related Peptide (CGRP) Inhibitors Class

New Therapeutic Class Could Bring Relief to Migraine Sufferers, But At What Cost?

Perspective on the Rx Pipeline - The Pros and Cons of the Calcitonin Gene-Related Peptide (CGRP) Inhibitors Class

CDC Advisory Committee Makes First Product-Specific Recommendation for Shingles Vaccine

Perspective on the Rx Pipeline - Shingrix

First Hepatitis C Medication to Offer Eight-Week Treatment Now Available

Perspective on the Rx Pipeline - Mavyret™

Patent Settlements Give Rise to Generic Versions of Popular Blue Pill, but — For A Time — the Brand ...

Perspective on the Rx Pipeline - Viagra®

Prev
1
2
Next

EnvisionRx

800-361-4542

Follow Us

Instant Insights

Not getting email updates?

© 2020 EnvisionRx All rights reserved | Terms & Conditions | Privacy Policy